Skip to main content
Erschienen in: Journal of Neural Transmission 11/2019

28.09.2019 | Neurology and Preclinical Neurological Studies - Original Article

“New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction”

verfasst von: Justyna Dutkiewicz, Stanisław Szlufik, Andrzej Friedman

Erschienen in: Journal of Neural Transmission | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to assess quantitatively sweating in PD patients. In the study, the galvanic-skin reaction (GSR) was used. The GSR was tested using eSense Skin Reaction device. The results show that sweating in patients with Parkinson’s disease on drugs (PD ON) and control patients is similar, while patients with PD without levodopa (PD OFF) have higher perspiration.
Literatur
Zurück zum Zitat Augustis S, Saferis V, Jost WH (2017) Autonomic disturbances including impaired hand thermoregulation in multiple system atrophy and Parkinson/s disease. J Neural Transm 124:965–972CrossRef Augustis S, Saferis V, Jost WH (2017) Autonomic disturbances including impaired hand thermoregulation in multiple system atrophy and Parkinson/s disease. J Neural Transm 124:965–972CrossRef
Zurück zum Zitat Beitz JM (2014) Parkinson’s disease: a review. Front Biosci 6:65–74 (Schol Ed) CrossRef Beitz JM (2014) Parkinson’s disease: a review. Front Biosci 6:65–74 (Schol Ed) CrossRef
Zurück zum Zitat Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M (2013) EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease. Eur J Neurol 20(1):16–34CrossRef Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M (2013) EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease. Eur J Neurol 20(1):16–34CrossRef
Zurück zum Zitat Dutkiewicz J, Szlufik S, Nieciecki M, Charzyńska I, Królicki L, Smektała P, Friedman A (2015) Small intestine dysfunction in Parkinson’s disease. J Neural Transm (Vienna) 122(12):1659–1661CrossRef Dutkiewicz J, Szlufik S, Nieciecki M, Charzyńska I, Królicki L, Smektała P, Friedman A (2015) Small intestine dysfunction in Parkinson’s disease. J Neural Transm (Vienna) 122(12):1659–1661CrossRef
Zurück zum Zitat Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 42(4):726–732CrossRef Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 42(4):726–732CrossRef
Zurück zum Zitat Gomez-Esteban JC, Tijero B, Somme J et al (2011) Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease. J Neurol 258(3):494–499CrossRef Gomez-Esteban JC, Tijero B, Somme J et al (2011) Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease. J Neurol 258(3):494–499CrossRef
Zurück zum Zitat Huang YP, Chen LS, Yen MF, Fann CY, Chiu YH, Chen HH, Pan SL (2013) Parkinson’s Disease is related to an increased risk of ischemic stroke—a population-based propensity score-matched follow-up study. PLoS ONE 8(9):e68314CrossRef Huang YP, Chen LS, Yen MF, Fann CY, Chiu YH, Chen HH, Pan SL (2013) Parkinson’s Disease is related to an increased risk of ischemic stroke—a population-based propensity score-matched follow-up study. PLoS ONE 8(9):e68314CrossRef
Zurück zum Zitat Katunina E, Titova N (2017) The epidemiology of nonmotor symptoms in Parkinson’s disease (cohort and other studies). Int Rev Neurobiol 133:91–110CrossRef Katunina E, Titova N (2017) The epidemiology of nonmotor symptoms in Parkinson’s disease (cohort and other studies). Int Rev Neurobiol 133:91–110CrossRef
Zurück zum Zitat Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O’Brien JT, Brooks DJ, Barker RA, Burn DJ (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276–281CrossRef Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O’Brien JT, Brooks DJ, Barker RA, Burn DJ (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276–281CrossRef
Zurück zum Zitat Krygowska-Wajs A, William P, Cheshire Jr, Wszolek Z, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, Moskala M, Sowa-Staszczak A (2009) Evaluation of gastric emptying in familial and sporadic Parkinson diseas. Parkinsonism Relat Disord 15(9):692–696CrossRef Krygowska-Wajs A, William P, Cheshire Jr, Wszolek Z, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, Moskala M, Sowa-Staszczak A (2009) Evaluation of gastric emptying in familial and sporadic Parkinson diseas. Parkinsonism Relat Disord 15(9):692–696CrossRef
Zurück zum Zitat Marsili L, Rizzo G, Colosimo C (2018) Diagnostic criteria for parkinson’s disease: from james parkinson to the concept of prodromal disease. Front Neurol 9:156CrossRef Marsili L, Rizzo G, Colosimo C (2018) Diagnostic criteria for parkinson’s disease: from james parkinson to the concept of prodromal disease. Front Neurol 9:156CrossRef
Zurück zum Zitat Martignoni E, Godi L, Pacchetti C, Berardesca E, Vignoli GP, Albani G, Mancini F, Nappi G (1997) Is seborrhea a sign of autonomic impairment in Parkinson’s disease? J Neural Transm (Vienna) 104(11–12):1295–1304CrossRef Martignoni E, Godi L, Pacchetti C, Berardesca E, Vignoli GP, Albani G, Mancini F, Nappi G (1997) Is seborrhea a sign of autonomic impairment in Parkinson’s disease? J Neural Transm (Vienna) 104(11–12):1295–1304CrossRef
Zurück zum Zitat Potulska A, Friedman A, Królicki L, Spychala A (2003) Swallowing disorder in Parkinson’s disease. Parkinsonism Relat Disord 9(6):349–353CrossRef Potulska A, Friedman A, Królicki L, Spychala A (2003) Swallowing disorder in Parkinson’s disease. Parkinsonism Relat Disord 9(6):349–353CrossRef
Zurück zum Zitat Rajagopal R, Mallya NB (2014) Comparative evaluation of botulinum toxin versus iontophoresis with topical aluminium chloride hexahydrate in treatment of palmar hyperhidrosis. Med J Armed Forces India 70(3):247–252CrossRef Rajagopal R, Mallya NB (2014) Comparative evaluation of botulinum toxin versus iontophoresis with topical aluminium chloride hexahydrate in treatment of palmar hyperhidrosis. Med J Armed Forces India 70(3):247–252CrossRef
Zurück zum Zitat Rystedt A, Karlqvist M, Bertilsson M, Naver H, Swartling C (2013) Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study. Acta Derm Venereol 93(6):674–678CrossRef Rystedt A, Karlqvist M, Bertilsson M, Naver H, Swartling C (2013) Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study. Acta Derm Venereol 93(6):674–678CrossRef
Zurück zum Zitat Schestatsky P, Valls-Solé J, Ehlers JA, Rieder CR, Gomes I (2006) Hyperhidrosis in Parkinson’s disease. Mov Disord 21(10):1744–1748CrossRef Schestatsky P, Valls-Solé J, Ehlers JA, Rieder CR, Gomes I (2006) Hyperhidrosis in Parkinson’s disease. Mov Disord 21(10):1744–1748CrossRef
Zurück zum Zitat Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G et al (2006) Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 37:1184–1188CrossRef Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G et al (2006) Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 37:1184–1188CrossRef
Zurück zum Zitat Sun Y, Chang YH, Chen HF, Su YH, Su HF et al (2012) Risk of Parkinson disease onset in patients with diabetes. Diabetes Care 35:1047–1049CrossRef Sun Y, Chang YH, Chen HF, Su YH, Su HF et al (2012) Risk of Parkinson disease onset in patients with diabetes. Diabetes Care 35:1047–1049CrossRef
Zurück zum Zitat Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, Damanhouri GA, Kamal MA (2012) A synopsis on the role of tyrosine hydroxylase in Parkinson’s disease. CNS Neurol Disord: Drug Targets 11(4):395–409CrossRef Tabrez S, Jabir NR, Shakil S, Greig NH, Alam Q, Abuzenadah AM, Damanhouri GA, Kamal MA (2012) A synopsis on the role of tyrosine hydroxylase in Parkinson’s disease. CNS Neurol Disord: Drug Targets 11(4):395–409CrossRef
Zurück zum Zitat Wolters ECh, Braak H (2006) Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309–319 Wolters ECh, Braak H (2006) Parkinson’s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309–319
Metadaten
Titel
“New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction”
verfasst von
Justyna Dutkiewicz
Stanisław Szlufik
Andrzej Friedman
Publikationsdatum
28.09.2019
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 11/2019
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-019-02060-6

Weitere Artikel der Ausgabe 11/2019

Journal of Neural Transmission 11/2019 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Review Article

Salivary alpha-synuclein as a biomarker for Parkinson’s disease: a systematic review

Neurology and Preclinical Neurological Studies - Original Article

Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson’s disease

Neurology and Preclinical Neurological Studies - Original Article

Bound, free, and total l-dopa measurement in plasma of Parkinson’s disease patients

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.